Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Non-cash Items (2019 - 2025)

Historic Non-cash Items for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to $96.2 million.

  • IDEAYA Biosciences' Non-cash Items rose 665.19% to $96.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $96.2 million, marking a year-over-year increase of 665.19%. This contributed to the annual value of $96.2 million for FY2025, which is 665.19% up from last year.
  • IDEAYA Biosciences' Non-cash Items amounted to $96.2 million in Q4 2025, which was up 665.19% from $108.4 million recorded in Q3 2025.
  • Over the past 5 years, IDEAYA Biosciences' Non-cash Items peaked at $118.8 million during Q2 2025, and registered a low of $41400.0 during Q4 2021.
  • For the 5-year period, IDEAYA Biosciences' Non-cash Items averaged around $60.3 million, with its median value being $47.3 million (2023).
  • Its Non-cash Items has fluctuated over the past 5 years, first surged by 6753285.02% in 2022, then surged by 665.19% in 2025.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Non-cash Items stood at $41400.0 in 2021, then skyrocketed by 67532.85% to $28.0 million in 2022, then soared by 46.79% to $41.1 million in 2023, then surged by 119.46% to $90.2 million in 2024, then grew by 6.65% to $96.2 million in 2025.
  • Its Non-cash Items stands at $96.2 million for Q4 2025, versus $108.4 million for Q3 2025 and $118.8 million for Q2 2025.